SARS-CoV-2 and Dysphagia: A Retrospective Analysis of COVID-19 Patients with Swallowing Disorders

被引:0
|
作者
Molino, Christopher [1 ]
Bergantini, Laura [1 ]
Santucci, Silvia [2 ]
Pitinca, Marialuigia Tomai [2 ]
d'Alessandro, Miriana [1 ]
Cameli, Paolo [1 ]
Taddei, Sabrina [2 ]
Bargagli, Elena [1 ]
机构
[1] Siena Univ, Univ Hosp Siena, Dept Med Sci Surg & Neurosci, Resp Dis & Lung Transplant Unit, Viale Bracci, I-53100 Siena, Italy
[2] AOUS, UOP Riabilitaz, Siena, Italy
关键词
Dysphagia; Covid-19; Respiratory impariment; Rehabilitation; Speech-therapy; RISK;
D O I
10.1007/s00455-024-10715-0
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: COVID-19 can lead to impairment of neural networks involved in swallowing, since the act of swallowing is coordinated and performed by a diffuse brain network involving peripheral nerves and muscles. Dysphagia has been identified as a risk and predictive factor for the severest form of SARS-CoV-2 infection. Objectives: To investigate the association between swallowing disorders and COVID-19 in patients hospitalized for COVID-19. Methods: We collected demographic data, medical information specific to dysphagia and data on medical treatments of patients with COVID-19. Results: A total of 43 hospitalized COVID-19 patients were enrolled in the study. Twenty (46%) were evaluated positive for dysphagia and 23 (54%) were evaluated negative. Neurocognitive disorders and diabetes were mostly associated with patients who resulted positive for dysphagia. Respiratory impairment caused by COVID-19 seems to be a cause of dysphagia, since all patients who needed oxygen-therapy developed symptoms of dysphagia, unlike patients who did not. In the dysphagic group, alteration of the swallowing trigger resulted in the severest form of dysphagia. An association was found between the severest form of COVID-19 and dysphagia. This group consisted predominantly of males with longer hospitalization. Conclusions: Identification of COVID-19 patients at risk for dysphagia is crucial for better patient management.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 50 条
  • [31] Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19
    Carmo, Analia
    Pereira-Vaz, Joao
    Mota, Vanda
    Mendes, Alexandra
    Morais, Celia
    da Silva, Andreia Coelho
    Camilo, Elisabete
    Pinto, Catarina Silva
    Cunha, Elizabete
    Pereira, Janet
    Coucelo, Margarida
    Martinho, Patricia
    Correia, Lurdes
    Marques, Gilberto
    Araujo, Lucilia
    Rodrigues, Fernando
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 2227 - 2231
  • [32] SARS-CoV-2 is not found in the sweat of COVID-19 positive patients
    Arslan, Bengi
    Bercin, Sami
    Aydogan, Sibel
    Islamoglu, Yuce
    Dinc, Bedia
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (01) : 27 - 29
  • [33] SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients
    Lawrence Panchali, Merlin Jayalal
    Kim, Choon-Mee
    Seo, Jun-Won
    Kim, Da-Young
    Yun, Na-Ra
    Kim, Dong-Min
    VIRUSES-BASEL, 2023, 15 (07):
  • [34] SARS-CoV-2 and COVID-19: A Narrative Review
    Blann, A. D.
    Heitmar, R.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [35] SARS-CoV-2 (COVID-19) and cystic fibrosis
    Stanton, Bruce A.
    Hampton, Thomas H.
    Ashare, Alix
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (03) : L408 - L415
  • [36] Impact of SARS-CoV-2/COVID-19 on the placenta
    Menter, T.
    Tzankov, A.
    Bruder, E.
    PATHOLOGE, 2021, 42 (06): : 591 - 597
  • [37] SARS-COV-2 as potential microRNA sponge in COVID-19 patients
    Li, Chang
    Wang, Rebecca
    Wu, Aurora
    Yuan, Tina
    Song, Kevin
    Bai, Yongsheng
    Liu, Xiaoming
    BMC MEDICAL GENOMICS, 2022, 15 (SUPPL 2)
  • [38] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Egbert Piasecki
    Archivum Immunologiae et Therapiae Experimentalis, 2020, 68
  • [39] COVID-19: implications of SARS-CoV-2 in Colombia
    Almeida-Espinosa, Alexander
    Sarmiento-Ardila, Jorge A.
    GACETA MEDICA DE MEXICO, 2020, 156 (04): : 334 - 338
  • [40] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515